Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 25 of 28
Can We Improve Cardiovascular Risk in Type 2 Diabetes?
Mechanisms of Enhanced Cardiovascular Disease with Type 2 Diabetes
Matthew Aaron Cavender, MD, MPH
University of North Carolina, Chapel Hill, NC
from ENDO 2017 on April 3, 2017 8:00 AM-9:30 AM
Can We Improve Cardiovascular Risk in Type 2 Diabetes?
Cardiovascular Benefits and Consequences of Diabetes Medications
Jennifer Brigitte Green, MD
Duke Univ Med Ctr, Durham, NC
from ENDO 2017 on April 3, 2017 8:00 AM-9:30 AM
Can We Improve Cardiovascular Risk in Type 2 Diabetes?
The Future of Cardiovascular Disease Prevention in Type 2 Diabetes
William T Cefalu, MD
Pennington Biomedical Reserach Center, Baton Rouge, LA
from ENDO 2017 on April 3, 2017 8:00 AM-9:30 AM
Obesity: Prevention Strategies, Treatment Paradigms, and Research Needs for 2016 and Beyond
Welcome and Introduction
John Germak, MD
Global Medical Team Lead (GMTL), Shire
from ENDO 2016 on April 1, 2016 4:45 PM-6:15 PM
Obesity: Prevention Strategies, Treatment Paradigms, and Research Needs for 2016 and Beyond
Obesity Research: Current Science and Path Forward
Michael W. Schwartz, MD
University of Washington, Seattle, WA
from ENDO 2016 on April 1, 2016 4:45 PM-6:15 PM
Obesity: Prevention Strategies, Treatment Paradigms, and Research Needs for 2016 and Beyond
Pharmaceutical Industry's Collaborative Role in Addressing the Patient's Unmet Need
Kevin L. Grove, PhD
Novo Nordisk Inc., ,
from ENDO 2016 on April 1, 2016 4:45 PM-6:15 PM
Obesity: Prevention Strategies, Treatment Paradigms, and Research Needs for 2016 and Beyond
Obesity Pharmacotherapy for Children and Adolescents: Today and Future Directions
Jack Adam Yanovski, MD, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD
from ENDO 2016 on April 1, 2016 4:45 PM-6:15 PM
Obesity: Prevention Strategies, Treatment Paradigms, and Research Needs for 2016 and Beyond
Panel Discussion
John Germak, MD
Global Medical Team Lead (GMTL), Shire
from ENDO 2016 on April 1, 2016 4:45 PM-6:15 PM
Challenges in Transition from Pediatric to Adult Care
Long-Term Management and Outcomes in Congenital Adrenal Hyperplasia
Perrin C White, MD
UT Southwestern Medical Center, Dallas, TX
from ENDO 2016 on April 2, 2016 8:15 AM-9:45 AM
Challenges in Transition from Pediatric to Adult Care
Transition of Care for the Patient with Hypopituitarism
Julia Kharlip, MD
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
from ENDO 2016 on April 2, 2016 8:15 AM-9:45 AM
Hyperinsulinism in Infancy and Childhood
Chair
Charles A Stanley, MD
The Children's Hospital of Philadelphia, Philadelphia, PA
from ENDO 2016 on April 2, 2016 4:45 PM-6:15 PM
Hyperinsulinism in Infancy and Childhood
The Role of Genetic Testing for Hyperinsulinism
Sian Ellard, PhD, FRCPath
University of Exeter Medical School, , United Kingdom
from ENDO 2016 on April 2, 2016 4:45 PM-6:15 PM
Hyperinsulinism in Infancy and Childhood
Diagnosis, Management, and Long-Term Outcomes
Diva Del Carmen De Leon-Crutchlow, MD, MSCE
Children's Hospital of Philadelphia, Philadelphia, PA
from ENDO 2016 on April 2, 2016 4:45 PM-6:15 PM
Hyperinsulinism in Infancy and Childhood
New Therapeutic Approaches: mTOR Inhibitors and Beyond
Khalid Hussain, MBChB, MRCP, MD, MSc, MRCPCH
UCL Institute of Child Health/Great Ormond Street Hospital, London, United Kingdom
from ENDO 2016 on April 2, 2016 4:45 PM-6:15 PM
New Technologies in Type 1 Diabetes
New Insulins: Are They Getting Better?
Chantal Mathieu, MD, PhD
Catholic University Leuven (KU Leuven), Leuven, Belgium
from ENDO 2016 on April 3, 2016 4:45 PM-6:15 PM
New Technologies in Type 1 Diabetes
CGM: Past, Present, and Future
Larry A Fox, MD
Nemours Children's Health System, Jacksonville, FL
from ENDO 2016 on April 3, 2016 4:45 PM-6:15 PM
New Technologies in Type 1 Diabetes
Automating Glycemic Management in Diabetes Mellitus With a Bionic Pancreas
Steven Jon Russell, MD, PhD
Massachusetts General Hospital, Boston, MA
from ENDO 2016 on April 3, 2016 4:45 PM-6:15 PM
Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options
Welcome and Introduction
Bernard Zinman
University of Toronto, Toronto, ON
from Ancillary Symposia 2016 on April 3, 2016 6:30 PM-9:30 PM
Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options
Cardiovascular Risk Screening and Prevention: Who, When, How Often, What Medication?
Naveed Sattar, PhD, FRCP, FRCPath
University of Glasgow, Glasgow, United Kingdom
from Ancillary Symposia 2016 on April 3, 2016 6:30 PM-9:30 PM
Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options
Cardiovascular Effects of Medications for Glycemic Control: Evidence from Large Outcomes Trials
Hertzel C Gerstein, MD,MSc,FRCPC
McMaster University, Hamilton, ON
from Ancillary Symposia 2016 on April 3, 2016 6:30 PM-9:30 PM
Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options
SGLT-2 Inhibitors - Cardiovascular Impact and Safety Concerns
Silvio E Inzucchi, MD
Yale School of Medicine, New Haven, CT
from Ancillary Symposia 2016 on April 3, 2016 6:30 PM-9:30 PM
Updates in Cardiovascular Risk Reduction in Type 2 Diabetes: New Insights and Outcomes in Treatment Options
Panel Discussion and Audience Questions
Bernard Zinman
University of Toronto, Toronto, ON
from Ancillary Symposia 2016 on April 3, 2016 6:30 PM-9:30 PM
New Frontiers in Osteoporosis: Targets in Bone Remodeling
Welcome and Introduction
Michael R McClung, MD
Oregon Osteoporosis Center, Portland, OR
from Ancillary Symposia 2016 on April 3, 2016 5:45 AM-8:00 AM
New Frontiers in Osteoporosis: Targets in Bone Remodeling
Update on Current State of Osteoporosis Therapy
Paul D Miller, MD
Colorado Center for Bone Research, Lakewood, CO
from Ancillary Symposia 2016 on April 3, 2016 5:45 AM-8:00 AM
New Frontiers in Osteoporosis: Targets in Bone Remodeling
Cathepsin K Inhibitors as an Emerging Antiresoptive
Bente Lomholt Langdahl, PhD, DMSc
Aarhus University Hospital, Aarhus, Denmark
from Ancillary Symposia 2016 on April 3, 2016 5:45 AM-8:00 AM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 25 of 28